Why is infectious disease screening included in infertility evaluation?

• A. To evaluate male fertility potential.
• B. To determine antibiotic susceptibility of pathogens.
• C. To diagnose genetic conditions.
• D. To detect infections that can impact fertility.

Answer: (D)

Infectious disease screening is included because infections of the reproductive tract can directly affect fertility, even when there are no symptoms. Detecting infections such as Chlamydia, gonorrhea, and other sexually transmitted or opportunistic pathogens allows timely treatment to prevent or limit tubal damage, endometritis, epididymal or seminal infections, and other factors that reduce fertility. It also helps reduce transmission to a partner or fetus, which is especially important if assisted reproductive techniques are planned. By identifying and treating infections before attempting conception, fertility outcomes are improved and safety during pregnancy or ART procedures is enhanced.

This isn’t about evaluating male fertility potential specifically (that relies more on semen analysis and related tests), nor is it about antibiotic susceptibility testing or diagnosing genetic conditions. The goal of infectious screening in this context is to detect infections that can directly impact reproductive ability and pregnancy outcomes.